Your Mounjaro price guide · October 2026
Does Mounjaro Eventually Stop Working? (October 2026)
Mounjaro is not described as a medicine that wears off, but weight loss does slow and can stall as the body adapts to a lower weight. Plateaus of a few weeks are normal and expected. Within the licence, the responses to a plateau are reviewing food intake, protecting protein and activity, and asking your prescriber whether a dose step-up is appropriate. Prices checked 10 October 2026.
One pen. Four weekly doses.
New customers£40 off your first order with code FIRST40. Standard price £169.99.

From your first consultation to ongoing care.
- GPhC-registered UK pharmacy
- Prescriber assessment
- Temperature-controlled delivery
- Advice from our pharmacy team
Why Mounjaro seems to stop
Most people who feel Mounjaro has stopped working are seeing a normal slowdown, an early-phase expectation gap or drifting habits.
- Price includes prescriber assessment and standard delivery — no consultation fees
- Orders approved by 3pm for next-day tracked delivery
- GPhC-registered pharmacy 9012878
- Needles and sharps disposal included
Compare UK Mounjaro Prices
Prices checked 10 October 2026
| Provider | 2.5mg | 5mg | 7.5mg | 10mg | 12.5mg | 15mg | Notes |
|---|---|---|---|---|---|---|---|
| £129.99First orderReorders £144.99 | £178.99First orderReorders £193.99 | £239.99First orderReorders £254.99 | £250.99First orderReorders £265.99 | £279.99First orderReorders £294.99 | £289.99First orderReorders £304.99 | Consultation and next-day tracked delivery included | |
| Boots Online Doctor | £179.00 | £199.00 | £259.00 | £299.00 | £319.00 | £339.00 | Free click & collect; cold-chain home delivery chargeable |
| Asda Online Doctor | £148.97 | £188.97 | £248.97 | £278.97 | £287.47 | £298.97 | Refrigerated delivery from £4.50; free click & collect |
| MedExpress | £179.99 | £189.99 | £249.99 | £279.99 | £299.99 | £309.99 | Delivery £2.90 to £3.95; new-customer discount at checkout |
| Simple Online Pharmacy | £169.00 | £199.99 | £259.99 | £279.99 | £299.99 | £319.99 | Delivery £4.99 per order |
| Oxford Online Pharmacy | £143.96 | £188.96 | £248.96 | £278.96 | £288.96 | £309.95 | Free consultation; cold delivery £5.49 |
| Chemist4U | £148.00 | £188.00 | £248.00 | £278.00 | £288.00 | £298.00 | Consultation included; free temperature-controlled delivery |
| Chemist Click | £163.99 | £173.99 | £232.99 | £259.99 | £279.99 | £299.49 | Cold-chain delivery charged; £20 off with code |
| Click Pharmacy | £169.99 | £189.99 | £239.99 | £269.99 | £289.99 | £299.99 | Free assessment; delivery £3.50 to £7.95 |
| Medino | £147.99 | £169.99 | £249.99 | £269.99 | £299.99 | £319.99 | Consultation and delivery included |
Prices collected weekly from each provider's published price list.
A quick overview
What to know
before you start.
-
A plateau of a few weeks is normal and expected; it is not the same as the medicine failing.
-
Weight loss builds gradually, so judge progress by trend over months, not single weigh-ins.
-
Review food intake, protein, activity, sleep and alcohol before assuming the dose has stopped working.
-
If you are not yet at the highest dose, ask your prescriber whether a step-up is appropriate.
In this guide
01 · The core answer
Does Mounjaro eventually stop working? The short answer
Mounjaro does not switch off at a set point, but the pace of loss changes over time. Early progress often feels fast because it includes water weight, then the curve flattens as the body adapts to a lower weight. That flattening is the pattern people describe as "it has stopped working", and in most cases it is a plateau rather than a failure of the medicine.4
Weight loss on Mounjaro is not linear. Plateaus of a few weeks are normal and expected as the body adapts to a lower weight.11 That is different from months of no change at the top tolerated dose, which your prescriber should look at properly.
Tirzepatide activates two natural gut-hormone receptors, GIP and GLP-1, which help regulate appetite and slow how quickly the stomach empties.1 Those actions continue for as long as you keep taking the medicine at the licensed weekly interval. What changes is the starting point: a smaller body needs less energy, and eating habits can drift back without anyone noticing.
02 · Decide
Which situation are you in?
Three situations get confused with each other, and the right response differs for each. Use the situations to decide whether to wait, adjust habits or speak to your prescriber.
| Situation | What it usually looks like | Sensible next step |
|---|---|---|
| Early phase on the starter dose | Modest change, little appetite shift, early weeks on 2.5mg | Keep going; the dose you respond to may still be ahead of you4 |
| A plateau of a few weeks | Scales flat after a period of steady loss | Review food intake, protein, activity, sleep and alcohol; ask about a step-up if not at maximum |
| Little response at the highest tolerated dose | Months of minimal change despite good habits | Prescriber review of continuing, adjusting or stopping |
| Side effects limiting the dose | Nausea or tiredness stopping you stepping up | Discuss with the prescribing team; report new symptoms through the Yellow Card scheme19 |
The formal check is built into treatment. Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.4
03 · Next step
What to do next
Start with an honest look at the basics before assuming the dose has failed. Portions drift upward, protein falls, activity quietly drops and sleep or alcohol habits change. Keep a simple record for a few weeks and look at the trend rather than individual days. Our free GLPTrackr companion app is built for tracking a GLP-1 journey.
Then talk to a clinician. If you already take Mounjaro with us, the prescribing team can look at your dose, side effects and progress together. Our broader weight loss clinic page explains how treatment and support fit together.
Whatever you do, a plateau is not a reason to double doses or add unlicensed products.11
Mounjaro (tirzepatide) is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary.
04 · Why weight loss slows
Why weight loss slows on Mounjaro
Weight loss slows because the body adapts to a lower weight, not because the medicine suddenly stops acting. Plateaus of a few weeks are normal and expected as this adaptation happens.11 Understanding that pattern removes much of the alarm when the scales stop moving after a good run.
Early results can look faster than the steady trend for a simple reason. The first weeks include water weight, so the early drop is not all fat. As that settles, the underlying trend becomes clearer and usually looks slower than the first fortnight suggested. This is why prescribers ask you to judge progress by trend over weeks, not by individual weigh-ins.4
The mechanism itself is steady. Tirzepatide activates two natural gut-hormone receptors at once, helping regulate appetite, slow how quickly the stomach empties and improve the way the body responds to insulin. In practice most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.1 That support depends on you still eating in a way that creates a calorie gap.
Here is where the feeling of "it has stopped working" often begins. When appetite is quiet, portions shrink without effort. Weeks later, as the novelty fades, portions creep back, snacks return and liquid calories add up. Because the medicine is still reducing hunger, it does not feel like overeating, but the energy balance has shifted enough to flatten the curve.
The headline trial figures show what sustained treatment can deliver. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.2 These are trial averages, and individual results vary.
Notice the shape of that result. It was measured across 72 weeks, with loss building month by month rather than arriving in a rush. A flat month inside a long trajectory is entirely consistent with those averages. What matters is whether the longer trend, across several months, is still heading in the right direction at the dose you are on.
If it is not, the answer is a conversation with your prescriber, not a private experiment.
05 · The weekly cycle
The seven-day cycle and late-week hunger
Hunger that returns later in the week does not on its own mean the medicine has failed. Mounjaro is licensed as a once-weekly injection, and its blood levels are designed around a seven-day cycle.1 Some people notice appetite is quietest soon after the injection and returns toward the end of the cycle.
Tirzepatide has a half-life of about five days, so after a final dose it takes roughly 4–5 weeks to clear the system — there is no way to speed this up, and nothing needs doing while it clears.1 That long half-life is why it works as a weekly medicine, and it also means the effect fades slowly rather than switching off abruptly if you miss a dose or stop altogether.
Because experiences differ widely, there is no single correct pattern. Some people feel appetite change and early loss in week one, while others feel little until a higher dose. Both are normal.4 Mild nausea, altered appetite and tiredness in the first days after each injection are the commonest early effects and usually settle.
If late-week hunger bothers you, plan around it rather than blaming the pen. Build meals around protein and fibre-rich foods, keep planned snacks ready for the days when appetite returns, and avoid shopping or social plans that put the hardest day of the cycle next to the most tempting food. These are habit adjustments, not changes to the medicine.
What you should not do is change the injection interval. Taking it more or less often than weekly alters how levels rise and fall, and it is not licensed. Follow the instructions in the patient information leaflet and in the pen's own guidance, and keep the same day each week.
Appetite signals are also influenced by sleep, stress, alcohol and how much protein you eat, so a bad week of hunger does not necessarily trace back to the pen. Note when the hunger arrives, what you ate the day before and how you slept. That information makes any conversation with your prescriber far more useful.
Finally, remember that "food noise" differs from true hunger. A quieter mind around food is one of the effects people value most, and it can fluctuate. A noisy day does not mean the medicine has gone, and a pattern across several weeks is what deserves a review.
06 · Realistic pace
What a realistic pace looks like
A realistic pace is gradual by design, and many people who think treatment has stopped are simply early. Weight loss on Mounjaro is gradual: the first weeks on 2.5mg are an adjustment phase and losses are usually modest, with most measurable progress building from 5mg onward, month by month.4
Trials measured results at 72 weeks, so think in months, not days. Three months in, most people are still on the lower rungs of the dose ladder, so trial-average losses at this stage are modest compared with the headline figures. A sensible expectation on a standard titration is mid single digits as a percentage of body weight, with wide individual variation.2
Slower early progress does not predict failure, because the dose you respond to may still be ahead of you. Our guide to how long Mounjaro keeps working goes further into timing.
It also helps to know what the best-case figures represent. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.2 Those are trial outcomes, not promises, and they came with diet and activity changes.
Weight is not the only measure either. In trials, weight loss on tirzepatide came with average improvements in waist size, blood pressure, cholesterol and blood-sugar measures, and most participants with prediabetes returned to normal blood-sugar levels.2 If the scales are flat but your clothes fit differently or your health checks improve, treatment may still be doing useful work.
Set expectations accordingly. Take a weekly or fortnightly measurement at the same time of day, record the waist as well as the weight, and compare across a run of weeks. A single heavy day after a salty meal tells you almost nothing, while the direction across a longer window tells you a great deal.
If after several months at your highest tolerated dose the trend is still flat, that is the point at which the formal review applies. Until then, patience and good habits are usually the right answer rather than a change of medicine.
07 · Breaking a plateau
How to break a plateau safely
Break a plateau by working through the licensed responses in order, starting with the ones you control. Within the licence, the responses are: review food intake honestly because portions drift back up, protect protein and activity, check the basics such as sleep and alcohol, and discuss with your prescriber whether a dose step-up is appropriate if you are not yet at maximum.11
Begin with food. Weigh or measure portions for a short period, write down everything including drinks and snacks, and compare with what you were eating when loss was steady. Most plateaus reveal small, cumulative changes rather than one obvious culprit. Because appetite is reduced, extra calories slip in unnoticed.
Next, protect protein and movement. Increased physical activity is part of the licence, not an optional extra. Nothing special is required: the evidence-backed pattern is regular moderate activity such as brisk walking plus resistance work for muscle. Start where you are and build; on injection days with early side effects, lighter movement still counts.4
Then check sleep and alcohol. Poor sleep tends to raise appetite and lower the motivation to move, and alcohol adds calories while lowering the care you take over food choices. Neither needs perfection, but both are quick to improve and often make a visible difference within a few weeks.
If habits are sound and you have not reached the top of the ladder, ask whether a step-up is appropriate. Higher strengths are available in six steps from 2.5mg to 15mg, and your prescriber decides the pace based on tolerability and response.1
What you should avoid is just as important. A plateau is not a reason to double doses or add unlicensed products.11 Supplements marketed with dramatic weight-loss claims are low-cost and come with no clinical oversight, and they are not substitutes for a reviewed prescription treatment.
Finally, give each change time. Alter one thing, hold it for a few weeks and judge by trend. If you are on a steady dose that suits you and the scales have been flat for months, bring your record to your next monthly review. Our related guide on whether Mounjaro can stop working for weight loss covers the same ground from another angle.
08 · Stopping and regain
What the evidence says about stopping
Stopping treatment is the clearest way to see that Mounjaro was doing something, because weight tends to return. Mounjaro manages weight; it does not cure the biology behind it. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average.14
People who kept taking it did not just hold their weight; on average they lost more. It argues against the idea that the medicine inevitably fades, and it shows that apparent plateaus are often temporary on continued treatment.
Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load.14 Exercise also protects against regain if you later stop treatment, which is another reason regular movement belongs in the plan from the start rather than being added when problems appear.
If you are thinking of stopping because it "is not working", separate two motives. The first is lack of response, which a prescriber can assess. The second is side effects, which can sometimes be managed.
On side effects, the trial data show that most people tolerate the medicine well enough to continue. In SURMOUNT-1, 4.3% of people on 5mg, 7.1% on 10mg and 6.2% on 15mg stopped treatment because of side effects, compared with 2.6% on placebo.2 If side effects are the barrier for you, say so, because there may be options short of stopping.
When clearance is part of your plan, remember how it works. After a final dose it takes four to five weeks to clear the system, and nothing needs doing while it does. Appetite may return gradually over that period, so have your food routines ready before the last pen rather than after.
A planned conversation can also cover what maintenance looks like, how long to continue and what support you will have. Our reviewing team handles dose titration and follow-up assessments, so a decision to stop or hold should be a considered one rather than a reaction to a flat fortnight.
09 · Stretching doses
Why stretching doses is not the answer
Mounjaro is licensed as a once-weekly medicine; its blood levels are designed around a seven-day cycle.
This matters here because some people respond to a stall by changing how they use the pen. They skip weeks, split doses or try to make a pen last longer. Each of these changes the pharmacology the licence was built on, and none has evidence behind it. If results then worsen, it is impossible to tell whether the medicine or the improvisation is responsible.
Talk to your clinical team rather than self-adjusting.
Klarna and pay-monthly options are available, and there are no subscriptions, so you are never locked into anything. Repeat orders re-check suitability and there is no auto-shipping.
The key idea is that every change should happen inside the licence and with a clinician aware of it. That keeps safety, evidence and accountability in place.
10 · NHS and private review
Reviews, NHS access and private treatment
Whichever route you use, a stalled response deserves a proper review rather than guesswork. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).46
Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.6 Whether you are on the NHS or private, the same clinical logic applies to a plateau: check habits, consider dose, review response and plan any stop with a prescriber.
Private treatment with us follows a clear journey. You complete a free online consultation, a short health questionnaire with no charge and no obligation. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Our registered pharmacy (GPhC 9012878) dispenses and dispatches the same day when ordered by 3pm.
Delivery is free, next-day, tracked and sent in discreet, temperature-controlled packaging. Saturday delivery is £14.99. Supply is official LillyDirect supply, meaning genuine KwikPens direct from Eli Lilly's UK distribution, and all six doses are in stock. Needles, a sharps bin and injection guidance come with every order.
Aftercare is where plateaus get handled. Ongoing monthly reviews, dose titration and follow-up assessments are done by the prescribing team, with side-effect support. Support runs Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, account portal chat or phone on 0333 207 0413.
If a new symptom appears while you are troubleshooting, tell your prescriber and report suspected side effects through the Yellow Card scheme.19 Do not assume an unexplained symptom is part of the plateau. Store pens in the fridge until first use and follow the patient information leaflet for the in-use window of 30 days (not above 30°C).13
If you want to explore related questions, our guides on whether Mounjaro stops working over time and what happens after a year go deeper on longer timelines. For comparison with another weight-loss option, see our orlistat guide.
11 · Tolerance and other myths
Tolerance, age and other common worries
People often ask whether the body builds a tolerance to Mounjaro, and the honest answer is that plateaus are the documented pattern, not a tolerance that cancels the drug. Plateaus are described as normal as the body adapts to a lower weight.11
That said, the feeling of reduced effect is real for many people. It usually reflects the early, dramatic phase giving way to a steadier one, plus the slow drift of habits. Naming those causes helps because each has a practical fix, whereas "tolerance" has none you can act on yourself.
Belly fat is a common concern. There is no way to target fat loss from one body area. Trials reported average improvements in waist size alongside overall weight loss, which is a useful marker if the scales are stubborn.2 Measure your waist as well as your weight.
Another common worry is that online claims about "natural alternatives" can fix a stall. Low-cost supplements are available cheaply without assessment, with no clinical oversight, and dosing is not standardised. They are not equivalent to a licensed medicine, and we would not recommend replacing or combining them with treatment without speaking to a prescriber.
You might also wonder whether a different medicine is the answer. Some people switch products, but that is a decision for you and your prescriber, based on your history and tolerability, not a reflex response to a plateau. Our guide to Mounjaro and the contraceptive pill covers another practical point to check with your prescriber. Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed, so switch to a non-oral method, or add a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.
If any symptom is new, unusual or worrying, do not look for explanations online. Speak to your prescriber and report suspected side effects through the Yellow Card scheme.19 Calm, evidence-based review is the quickest route back to progress.
12 · Serious side effects
Serious side effects: when to get help straight away
Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.1 There is no proven way to prevent pancreatitis or gallbladder problems while taking Mounjaro; tell your prescriber before you start if you have ever had pancreatitis, gallstones or gallbladder disease.
How ordering works
How ordering works at EverydayMeds
Three steps, with our pharmacy team alongside you.
Step 1: Online consultation — 5–10 minutes
Complete a confidential health questionnaire covering BMI, medical history and current medication. No payment is taken until you're approved.
Step 2: Prescriber review — usually same day
A UK registered prescriber checks your suitability against the licensed criteria (BMI ≥30, or ≥27 with a weight-related condition) and contraindications, and confirms your starting dose.
Step 3: Next-day tracked delivery
Dispensed by our GPhC-registered pharmacy in temperature-controlled packaging with needles and a sharps bin included. Orders approved by 3pm for next-day tracked delivery.
Prescription and dispatch follow clinical approval. Confirm current delivery options when ordering.
Afterwards you're not on your own: dose-change reviews are built in before each step up, our pharmacist team is available for side-effect questions, and repeat orders re-check suitability rather than auto-shipping.
Your questions, answered
Mounjaro price UK — frequently asked questions
Answers to common questions about Mounjaro prices, NHS access and ongoing treatment.
Ask our pharmacy teamCan you build up a tolerance to Mounjaro?
Does Mounjaro get less effective over time?
Why would my Mounjaro stop working?
Do you eventually stop losing weight on Mounjaro?
How to break a plateau on Mounjaro?
When should I speak to a prescriber about my progress?
What happens if I stop Mounjaro because I think it is not working?
Is a plateau on Mounjaro normal?

Clinically reviewed by
Mahommed Zunaid Ayub Patel
Superintendent Pharmacist
Accountable for the safe running of our registered pharmacy — from dispensing checks to delivery.
GPhC registration no. 2217101 · check the GPhC register
- Reviewed
- Last updated
- Next review
How we source our information
How we source our information: every clinical statement on this page is drawn from the sources below. Our prices are shown live from our pharmacy's product listings, and competitor prices show the date they were collected.
Sources — 7 references
- Mounjaro KwikPen — Summary of Product Characteristics (SmPC), electronic medicines compendium (EMC), 2026
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med 2022;387:205–216
- NICE TA1026 — Tirzepatide for managing overweight and obesity, including the practical prescribing guide
- NHS England — Weight management injections: rollout guidance
- BNF — Tirzepatide: indications, dosing and safety information
- Mounjaro KwikPen — Patient Information Leaflet (emc)
- MHRA Yellow Card scheme — report a side effect
EverydayMeds is operated by OVIO Ltd · GPhC-registered pharmacy 9012878 · Registered premises, Leicester · Superintendent Pharmacist: Mahommed Zunaid Ayub Patel


